Balyasny Asset Management »

Arcutis Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.1M 437k 9.30
2024-03-31 $7.7M 781k 9.91
2023-09-30 $202k 38k 5.31
2023-03-31 $487k 44k 11.00

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
BlackRock
Frazier Life Sciences Management
BlackRock
Vanguard Group
State Street Corporation
Franklin Resources
Morgan Stanley
Citadel Advisors
Cormorant Asset Management
Geode Capital Management
Ensign Peak Advisors
Pivotal bioVenture Partners Investment Advisor

View all funds holding Arcutis Biotherapeutics